Island Pharmaceuticals Limited (ASX:ILA)
Australia · Delayed Price · Currency is AUD 0.4170
-0.0030 (-0.71%)
Sep 22, 2026, 2:58 PM AEST
Island Pharmaceuticals Revenue
In the fiscal year ending June 30, 2026, Island Pharmaceuticals had annual revenue of 282.66K AUD with 137.71% growth. Island Pharmaceuticals had revenue of 241.87K in the half year ending June 30, 2026, a decrease of -20.05%.
Revenue
282.66K
Revenue Growth
+137.71%
P/S Ratio
439.70
Revenue / Employee
n/a
Employees
n/a
Market Cap
124.29M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 282.66K | 163.75K | 137.71% |
| Jun 30, 2025 | 118.91K | -1.14M | -90.57% |
| Jun 30, 2024 | 1.26M | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthocell | 11.41M |
| Recce Pharmaceuticals | 9.47M |
| Dimerix | 6.35M |
| Alterity Therapeutics | 3.61M |
| Arovella Therapeutics | 3.50M |
| Prescient Therapeutics | 3.45M |
| Nyrada | 2.01M |
| Entropy Neurodynamics | 1.91M |